Cargando…

Levels of Impulsivity, Hyperactivity, and Inattention and the Association with Mental Health and Substance Use Severity in Opioid-Dependent Patients Seeking Treatment with Extended-Release Naltrexone

The level of impulsivity, hyperactivity, and inattention (IHI) is higher among patients with substance use disorder (SUD) than in the general population. However, the prevalence of such symptoms in patients seeking treatment with an opioid antagonist, such as extended-release naltrexone (XR-NTX), is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karlsson, Ann Tarja, Vederhus, John-Kåre, Clausen, Thomas, Weimand, Bente, Solli, Kristin Klemmetsby, Tanum, Lars
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509800/ https://www.ncbi.nlm.nih.gov/pubmed/34640572 http://dx.doi.org/10.3390/jcm10194558

Ejemplares similares

Impact of Impulsivity, Hyperactivity, and Inattention on Discontinuation Rate among Opioid-Dependent Patients Treated with Extended-Release Naltrexone
por: Karlsson, Ann Tarja, et al.
Publicado: (2022)

Personal recovery among people with opioid use disorder during treatment with extended-release naltrexone
por: Marciuch, Anne, et al.
Publicado: (2023)

Patients’ experiences of continued treatment with extended-release naltrexone: a Norwegian qualitative study
por: Marciuch, Anne, et al.
Publicado: (2022)

Enablers and hindrances for longer-term abstinence in opioid dependent individuals receiving treatment with extended-release naltrexone: A Norwegian longitudinal recovery trial (NaltRec study)
por: Weimand, B.M., et al.
Publicado: (2021)

Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX)
por: Kunøe, Nikolaj, et al.
Publicado: (2016)

Adapting treatment length to opioid‐dependent individuals’ needs and preferences: a 2‐year follow‐up to a 1‐year study of extended‐release naltrexone
por: Solli, Kristin Klemmetsby, et al.
Publicado: (2021)

Substance use in young adults with ADHD: Comorbidity and symptoms of inattention and hyperactivity/impulsivity
por: Miranda, Ana, et al.
Publicado: (2016)

Perceived family cohesion, social support, and quality of life in patients undergoing treatment for substance use disorders compared with patients with mental and physical disorders
por: Birkeland, Bente, et al.
Publicado: (2021)

Perceived quality of life in partners of patients undergoing treatment in somatic health, mental health, or substance use disorder units: a cross-sectional study
por: Birkeland, Bente, et al.
Publicado: (2017)

Discrepancy in Ratings of Shared Decision Making Between Patients and Health Professionals: A Cross Sectional Study in Mental Health Care
por: Drivenes, Karin, et al.
Publicado: (2020)

Self-Concept and Inattention or Hyperactivity–Impulsivity Symptomatology: The Role of Anxiety
por: Cueli, Marisol, et al.
Publicado: (2020)

High smoking and low cessation rates among patients in treatment for opioid and other substance use disorders
por: Bjørnestad, Endre Dahlen, et al.
Publicado: (2022)

Statistical Evidence Suggests that Inattention Drives Hyperactivity/Impulsivity in Attention Deficit-Hyperactivity Disorder
por: Sokolova, Elena, et al.
Publicado: (2016)

Temperamental predictors of developmental trajectories of inattention and hyperactivity–impulsivity problems in schoolchildren
por: Lee, Soo Jin, et al.
Publicado: (2017)

Dissociation in Neural Correlates of Hyperactive/Impulsive vs. Inattentive Symptoms in Attention-Deficit/Hyperactivity Disorder
por: Luo, Yu, et al.
Publicado: (2022)

Characterizing the heterogeneous course of inattention and hyperactivity-impulsivity from childhood to young adulthood
por: Vos, Melissa, et al.
Publicado: (2021)

Inattention, Impulsivity, and Hyperactivity among Individuals with Self-Reported Impaired Wound Healing
por: Balikji, Jessica, et al.
Publicado: (2022)

The Impact of Inattention, Hyperactivity/Impulsivity Symptoms, and Executive Functions on Learning Behaviors of Children with ADHD
por: Colomer, Carla, et al.
Publicado: (2017)

Hyperactivity, impulsivity, and inattention in boys with cleft lip and palate: relationship to ventromedial prefrontal cortex morphology
por: Nopoulos, Peggy, et al.
Publicado: (2010)

Correlations of gene expression with ratings of inattention and hyperactivity/impulsivity in tourette syndrome: a pilot study
por: Tian, Yingfang, et al.
Publicado: (2012)

Assessing understandings of substance use disorders among Norwegian treatment professionals, patients and the general public
por: Vederhus, John-Kåre, et al.
Publicado: (2016)

Inattention, Impulsivity, and Hyperactivity in Deaf Children Are Not Due to Deficits in Inhibitory Control, but May Reflect an Adaptive Strategy
por: Daza González, María Teresa, et al.
Publicado: (2021)

Canine hyperactivity, impulsivity, and inattention share similar demographic risk factors and behavioural comorbidities with human ADHD
por: Sulkama, Sini, et al.
Publicado: (2021)

Perceived quality of life, 6 months after detoxification: Is abstinence a modifying factor?
por: Vederhus, John-Kåre, et al.
Publicado: (2016)

Quality of Life in Patients with Substance Use Disorders Admitted to Detoxification Compared with Those Admitted to Hospitals for Medical Disorders: Follow-Up Results
por: Vederhus, John-Kåre, et al.
Publicado: (2016)

Mental distress following inpatient substance use treatment, modified by substance use; comparing voluntary and compulsory admissions
por: Pasareanu, Adrian R., et al.
Publicado: (2017)

Perceived coercion to enter treatment among involuntarily and voluntarily admitted patients with substance use disorders
por: Opsal, Anne, et al.
Publicado: (2016)

Probe-caught spontaneous and deliberate mind wandering in relation to self-reported inattentive, hyperactive and impulsive traits in adults
por: Arabacı, Gizem, et al.
Publicado: (2018)

Inattention and hyperactive/impulsive component scores do not differentiate between autism spectrum disorder and attention-deficit/hyperactivity disorder in a clinical sample
por: Krakowski, Aneta D., et al.
Publicado: (2020)

Eating problems in ADHD: self-regulatory or inattentive/impulsive
por: Araújo, A., et al.
Publicado: (2022)

Quality of life improved following in-patient substance use disorder treatment
por: Pasareanu, Adrian R, et al.
Publicado: (2015)

The influence of participation in target-shooting sport for children with inattentive, hyperactive and impulsive symptoms – A controlled study of best practice
por: Månsson, Annegrete Gohr, et al.
Publicado: (2017)

Yoga and music intervention reduces inattention, hyperactivity/impulsivity, and oppositional defiant disorder in children’s consumer with comorbid ADHD and ODD
por: Luo, Xue, et al.
Publicado: (2023)

Naltrexone extended-release injection: an option for the management of opioid abuse
por: Taylor, Robert, et al.
Publicado: (2011)

The Role of Impulsivity, Inattention and Comorbid ADHD in Patients with Bulimia Nervosa
por: Seitz, Jochen, et al.
Publicado: (2013)

Naltrexone Implant for Opioid Use Disorder
por: Edinoff, Amber N., et al.
Publicado: (2021)

Infralow neurofeedback in the treatment of substance use disorders: a randomized controlled trial
por: Gabrielsen, Karin Berle, et al.
Publicado: (2022)

Motivational intervention to enhance post-detoxification 12-Step group affiliation: a randomized controlled trial
por: Vederhus, John-Kåre, et al.
Publicado: (2014)

Characteristics and treatment preferences of individuals with opioid use disorder seeking to transition from buprenorphine to extended‐release naltrexone in a residential setting
por: Mannelli, Paolo, et al.
Publicado: (2022)

Improved drug-use patterns at 6 months post-discharge from inpatient substance use disorder treatment: results from compulsorily and voluntarily admitted patients
por: Pasareanu, Adrian R., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o2afe6va5qui9f59po6ec9sbt0